Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Eli Lilly and Company — Predicate Candidate Screening

5 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

261 daysmedian FDA review time
427 days90th percentile
5clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K212217Tempo Smart ButtonEli Lilly and Company2022-09-164270
K160949Go Dose SystemEli Lilly and Company2016-12-222610
K142518HumaPen LuxuraEli Lilly and Company2015-06-052700
K100988HUMAPEN LUXURA HDEli Lilly and Company2010-08-171300
K053563HUMAPEN MEMOIREli Lilly and Company2006-04-071070

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda